Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
SSP - E.W. Scripps Co. - Stock Price Chart
TickerSSP [NASD, RUT]
CompanyE.W. Scripps Co.
CountryUSA
IndustryBroadcasting
Market Cap173.10MEPS (ttm)-3.67
P/E-EPS this Y447.35%
Forward P/E-EPS next Y-148.79%
PEG-EPS past 5Y-
P/S0.07EPS next 5Y10.00%
P/B0.23EPS Q/Q98.12%
Dividend-Sales Q/Q-1.58%
Insider Own16.93%Inst Own68.60%
Insider Trans0.02%Inst Trans1.62%
Short Float6.16%EarningsAug 08/a
Analyst Recom3.00Target Price4.93
Avg Volume770.14K52W Range1.68 - 9.35
Sep-12-24 03:18AM E.W. Scripps Company (SSP): Short Sellers Are Bearish On This Broadcast Stock Now (Insider Monkey)
Sep-05-24 12:00PM Finalists announced for 71st Scripps Howard Journalism Awards (PR Newswire)
11:30AM Scripps promotes station leader to VP and general manager of WLEX in Lexington (PR Newswire)
Sep-04-24 11:00AM Court TV unveils fall primetime lineup featuring new and returning original series (PR Newswire)
07:00AM Double your impact: Scripps Howard Fund matches donations for 'If You Give a Child a Book ' campaign (PR Newswire)
Sep-02-24 07:09PM Where Does E.W. Scripps Company (SSP) Stand Among the Best Broadcasting Stocks to Buy? (Insider Monkey)
Aug-30-24 03:18AM Q2 Earnings Highs And Lows: Sinclair (NASDAQ:SBGI) Vs The Rest Of The Broadcasting Stocks (StockStory) -6.64%
Aug-29-24 08:31AM 10 Best Broadcasting Stocks to Buy (Insider Monkey)
Aug-27-24 04:31AM Broadcasting Stocks Q2 Results: Benchmarking E.W. Scripps (NASDAQ:SSP) (StockStory) -7.24%
Aug-26-24 04:18AM Q2 Earnings Highs And Lows: Gray Television (NYSE:GTN) Vs The Rest Of The Broadcasting Stocks (StockStory)
CURI - CuriosityStream Inc - Stock Price Chart
TickerCURI [NASD]
CompanyCuriosityStream Inc
CountryUSA
IndustryBroadcasting
Market Cap105.38MEPS (ttm)-0.72
P/E-EPS this Y78.62%
Forward P/E-EPS next Y50.85%
PEG-EPS past 5Y32.49%
P/S1.92EPS next 5Y46.80%
P/B1.60EPS Q/Q79.75%
Dividend2.59%Sales Q/Q-12.07%
Insider Own46.35%Inst Own7.29%
Insider Trans-4.24%Inst Trans-16.01%
Short Float1.48%EarningsAug 13/a
Analyst Recom1.67Target Price1.73
Avg Volume179.22K52W Range0.45 - 2.12
Sep-12-24 12:22PM Curiosity Expands FAST Distribution with Samsung TV Plus (Business Wire) +23.93%
02:27AM CuriosityStream Inc. (CURI): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-09-24 06:00AM CuriosityStream Inc. to Participate in the Singular Research Autumn Equinox Compelling Values Conference (Business Wire)
Sep-05-24 09:04AM Curiosity University Now Available on Prime Video (Business Wire)
Sep-02-24 08:50PM CuriosityStream Inc. (CURI): Evaluating Its Position Among the Top Broadcasting Stocks to Buy (Insider Monkey)
Aug-29-24 09:30AM Curiosity Channel Launches On Vodafone TV PLAY (Business Wire)
08:31AM 10 Best Broadcasting Stocks to Buy (Insider Monkey)
Aug-20-24 11:34PM Director Michael Nikzad Sells 181,265 Shares of CuriosityStream Inc (CURI) (GuruFocus.com)
Aug-13-24 04:05PM CuriosityStream Reports Q2 2024 Earnings Results (Business Wire) +9.17%
Aug-08-24 09:00AM CuriosityStream To Report Second Quarter 2024 Financial Results on August 13, 2024 (Business Wire)
BATL - Battalion Oil Corp - Stock Price Chart
TickerBATL [AMEX]
CompanyBattalion Oil Corp
CountryUSA
IndustryOil & Gas E&P
Market Cap49.54MEPS (ttm)-4.64
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B2.19EPS Q/Q-51.27%
Dividend-Sales Q/Q-8.91%
Insider Own15.19%Inst Own66.99%
Insider Trans0.00%Inst Trans0.82%
Short Float0.11%EarningsAug 14/a
Analyst Recom3.00Target Price18.60
Avg Volume14.96K52W Range2.48 - 9.69
Aug-16-24 12:50PM Battalion Oil (BATL) Earnings & Revenues Decline Y/Y in Q2 (Zacks)
Aug-14-24 04:15PM Battalion Oil Corporation Announces Second Quarter 2024 Financial and Operating Results (GlobeNewswire) +6.13%
May-15-24 04:32PM Battalion Oil Corporation Announces First Quarter 2024 Financial and Operating Results (GlobeNewswire)
Mar-29-24 07:44PM Battalion Oil Corporation Announces Fourth Quarter 2023 Financial and Operating Results (GlobeNewswire)
Feb-15-24 11:11AM Kuehn Law Encourages KAMN, SNCE, KRTX, and BATL Investors to Contact Law Firm (GlobeNewswire)
Feb-09-24 04:30PM Battalion Oil in Compliance with NYSE American Listing Standards (GlobeNewswire)
Jan-29-24 11:53PM SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates INBX, KAMN, BATL (PR Newswire)
09:00AM Battalion Oil Corporation Announces Operations and Financial Update (GlobeNewswire)
Jan-26-24 12:12PM Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law Firm (PR Newswire)
Jan-25-24 08:00AM SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NS, BATL, KAMN (GlobeNewswire) -10.06%
DSGN - Design Therapeutics Inc - Stock Price Chart
TickerDSGN [NASD, RUT]
CompanyDesign Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap313.67MEPS (ttm)-0.90
P/E-EPS this Y23.25%
Forward P/E-EPS next Y-28.47%
PEG-EPS past 5Y-138.68%
P/S-EPS next 5Y-
P/B1.20EPS Q/Q41.48%
Dividend-Sales Q/Q-
Insider Own43.30%Inst Own41.68%
Insider Trans-3.11%Inst Trans3.10%
Short Float6.83%EarningsAug 05/b
Analyst Recom2.33Target Price7.00
Avg Volume257.86K52W Range1.96 - 6.91
Sep-10-24 08:00AM Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference (GlobeNewswire) +15.69%
Aug-21-24 09:55AM Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet (Zacks)
Aug-05-24 08:00AM Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC Portfolio (GlobeNewswire)
May-22-24 08:50PM The 100%+ Club: Piper Sandler's 3 Top Picks for Triple-Digit Gains (InvestorPlace)
May-10-24 03:36PM Design Therapeutics Inc (DSGN) Q1 2024 Earnings: A Detailed Financial and Strategic Review (GuruFocus.com)
May-08-24 11:55PM DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones (GlobeNewswire)
May-07-24 07:12AM --Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral (MT Newswires) +28.49%
06:30AM Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Mar-20-24 10:31AM Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript (Insider Monkey) +11.97%
RMTI - Rockwell Medical Inc - Stock Price Chart
TickerRMTI [NASD]
CompanyRockwell Medical Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap120.24MEPS (ttm)-0.17
P/E-EPS this Y91.67%
Forward P/E55.36EPS next Y333.33%
PEG-EPS past 5Y44.20%
P/S1.27EPS next 5Y38.00%
P/B5.12EPS Q/Q104.98%
Dividend-Sales Q/Q42.88%
Insider Own11.59%Inst Own20.22%
Insider Trans0.00%Inst Trans9.94%
Short Float1.17%EarningsAug 08/b
Analyst Recom1.00Target Price7.50
Avg Volume366.31K52W Range1.16 - 4.38
Sep-09-24 12:00PM Rockwell Medical (RMTI) is a Great Momentum Stock: Should You Buy? (Zacks) +18.46%
08:50AM Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors (Zacks)
06:00AM Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider (Business Wire)
Sep-04-24 09:15AM Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-03-24 06:00AM Rockwell Medical Enters into Multi-Million Dollar Distribution Agreement with Nipro Medical Corporation (Business Wire) +13.29%
Aug-19-24 09:15AM Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run? (Zacks) +12.79%
Aug-15-24 08:50AM Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain (Zacks) +8.47%
Aug-08-24 07:15AM Rockwell Medical (RMTI) Tops Q2 Earnings and Revenue Estimates (Zacks) +20.90%
06:13AM Rockwell Medical: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024 (Business Wire)
KEQU - Kewaunee Scientific Corporation - Stock Price Chart
TickerKEQU [NASD]
CompanyKewaunee Scientific Corporation
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap104.88MEPS (ttm)6.23
P/E5.93EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y63.45%
P/S0.52EPS next 5Y-
P/B1.89EPS Q/Q-13.81%
Dividend-Sales Q/Q-2.90%
Insider Own27.12%Inst Own33.63%
Insider Trans-1.40%Inst Trans-1.09%
Short Float1.14%EarningsSep 11/a
Analyst Recom1.00Target Price28.00
Avg Volume31.28K52W Range16.50 - 55.62
Sep-11-24 04:46PM Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025 (PR Newswire)
Sep-04-24 10:00AM Kewaunee Scientific Corporation Announces Attendance at the 2024 Arablab Live Tradeshow and Conference (PR Newswire)
Aug-28-24 04:08PM Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025 (PR Newswire)
Jun-26-24 09:53PM KEQU Stock Earnings: Kewaunee Scientific Reported Results for Q4 2024 (InvestorPlace) +8.61% +10.20%
04:36PM Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter (PR Newswire)
Jun-12-24 04:18PM Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter (PR Newswire)
Mar-06-24 09:52PM KEQU Stock Earnings: Kewaunee Scientific Reported Results for Q3 2024 (InvestorPlace)
04:28PM Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024 (PR Newswire)
Feb-21-24 04:13PM Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024 (PR Newswire)
Dec-15-23 10:11PM Insider Buying: Director John Russell Acquires 7,500 Shares of Kewaunee Scientific Corp (GuruFocus.com)
RGC - Regencell Bioscience Holdings Ltd - Stock Price Chart
TickerRGC [NASD]
CompanyRegencell Bioscience Holdings Ltd
CountryHong Kong
IndustryDrug Manufacturers - Specialty & Generic
Market Cap70.25MEPS (ttm)-0.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-95.48%
P/S-EPS next 5Y-
P/B6.91EPS Q/Q35.97%
Dividend-Sales Q/Q-
Insider Own7.60%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.17%Earnings-
Analyst Recom-Target Price-
Avg Volume220.83K52W Range3.03 - 32.44
Jul-23-24 04:02PM What Is Going on With Regencell Bioscience (RGC) Stock Today? (InvestorPlace) +343.92% -9.76%
Nov-15-23 04:31PM 15 Developed Countries with Lowest Autism Rates (Insider Monkey) +11.11%
Jul-31-23 08:15AM With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.)
Apr-03-23 07:25AM One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year (Simply Wall St.)
Feb-21-23 06:36AM With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.) -5.99%
Nov-21-22 06:49AM Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth (Simply Wall St.)
Nov-15-22 07:55AM RGC: Forging a New Approach to ADHD and ASD (Zacks Small Cap Research)
Oct-25-22 06:55AM One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year (Simply Wall St.)
Sep-14-22 06:55AM 81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently (Simply Wall St.)
Sep-12-22 09:15AM Regencell Biosciences Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial (Business Wire)
SNOA - Sonoma Pharmaceuticals Inc. - Stock Price Chart
TickerSNOA [NASD]
CompanySonoma Pharmaceuticals Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap3.60MEPS (ttm)-10.04
P/E-EPS this Y55.81%
Forward P/E-EPS next Y55.88%
PEG-EPS past 5Y47.04%
P/S0.28EPS next 5Y-
P/B0.67EPS Q/Q76.64%
Dividend-Sales Q/Q-1.05%
Insider Own2.04%Inst Own2.12%
Insider Trans0.00%Inst Trans-
Short Float37.62%EarningsAug 13/a
Analyst Recom1.00Target Price26.00
Avg Volume197.12K52W Range2.32 - 20.40
Sep-11-24 08:30AM Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line (ACCESSWIRE)
Aug-28-24 06:10AM Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock (ACCESSWIRE) -24.99%
Aug-26-24 08:30AM Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff (ACCESSWIRE)
Aug-21-24 08:45AM Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States (ACCESSWIRE) -8.45%
Aug-12-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -9.48%
Aug-08-24 04:10PM Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results (ACCESSWIRE) +13.49% -19.70%
Jul-15-24 08:50AM Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-12-24 07:41AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-09-24 07:30AM Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine (ACCESSWIRE) -7.27%
Jun-28-24 08:50AM Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
LDI - LoanDepot Inc - Stock Price Chart
TickerLDI [NYSE]
CompanyLoanDepot Inc
CountryUSA
IndustryMortgage Finance
Market Cap494.38MEPS (ttm)-0.61
P/E-EPS this Y30.06%
Forward P/E18.73EPS next Y146.17%
PEG-EPS past 5Y6.34%
P/S0.49EPS next 5Y-
P/B1.65EPS Q/Q-31.08%
Dividend-Sales Q/Q7.16%
Insider Own64.20%Inst Own13.11%
Insider Trans-4.19%Inst Trans0.59%
Short Float3.94%EarningsAug 06/a
Analyst Recom3.17Target Price2.42
Avg Volume633.76K52W Range1.14 - 3.71
Sep-09-24 02:00PM loanDepot Appoints Nancy Smith as Regional Vice President for Colorado and Wyoming (Business Wire) +5.81%
Sep-03-24 03:47PM loanDepot President and CEO Frank Martell Receives Second Consecutive HousingWire Vanguard Award (Business Wire)
Aug-24-24 01:29AM Insider Sale: President of LDI Mortgage, Jeff Walsh, Sells 100,000 Shares of loanDepot Inc (LDI) (GuruFocus.com)
Aug-21-24 04:23PM loanDepot Launches equityFREEDOM First-Lien HELOC Further Expanding Home Equity Product Suite (Business Wire)
Aug-16-24 08:58AM Is the Options Market Predicting a Spike in loanDepot (LDI) Stock? (Zacks)
Aug-07-24 09:44AM Q2 2024 Loandepot Inc Earnings Call (Thomson Reuters StreetEvents) +11.11%
12:45AM loanDepot (LDI) Q2 2024 Earnings Call Transcript (Motley Fool)
Aug-06-24 08:00PM loanDepot (LDI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -6.33%
06:00PM LoanDepot (LDI) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
05:04PM LoanDepot: Q2 Earnings Snapshot (Associated Press Finance)
CALC - CalciMedica Inc - Stock Price Chart
TickerCALC [NASD]
CompanyCalciMedica Inc
CountryUSA
IndustryBiotechnology
Market Cap41.98MEPS (ttm)-1.88
P/E-EPS this Y79.05%
Forward P/E-EPS next Y30.69%
PEG-EPS past 5Y19.56%
P/S-EPS next 5Y-
P/B3.03EPS Q/Q68.09%
Dividend-Sales Q/Q-
Insider Own58.21%Inst Own18.37%
Insider Trans2.18%Inst Trans1.54%
Short Float0.53%EarningsAug 12/a
Analyst Recom1.00Target Price16.75
Avg Volume54.63K52W Range1.75 - 8.38
Sep-03-24 08:00AM CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +7.67%
Aug-12-24 04:10PM CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Jul-09-24 07:30AM CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) (PR Newswire)
Jul-08-24 08:00AM CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences (PR Newswire)
Jul-01-24 08:00AM CalciMedica Set to Join Russell Microcap Index (PR Newswire) +7.32%
Jun-27-24 08:00AM CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -32.40%
07:06AM CalciMedica's calcium channel inhibitor helps subgroup of pancreatitis patients eat solids sooner (FierceBiotech.com)
Jun-26-24 04:05PM CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -10.04%
May-28-24 07:53AM CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024 (InvestorPlace)
May-21-24 09:48AM 3 Massively Undervalued 10-Bagger Stocks to Buy (InvestorPlace)
1⋯10⋯121314151617181920
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.